COMPASS Pathways (CMPS) Research & Development (2021 - 2026)

COMPASS Pathways (CMPS) has 6 years of Research & Development data on file, last reported at $26.5 million in Q1 2026.

• Research & Development for Q1 2026 came in at $26.5 million, down 14.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $114.0 million (down 8.78% YoY), and the FY2025 annual result was $118.4 million, down 0.51% from the prior year.
• Research & Development slipped to $26.5 million in Q1 2026 per CMPS's latest filing, from $29.9 million in the prior quarter.
• Over five years, Research & Development peaked at $32.9 million in Q3 2024 and troughed at $14.0 million in Q3 2022.
• A 5-year average of $24.5 million and a median of $26.5 million in 2026 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2025: Research & Development soared 123.16% in 2022, then decreased 17.02% in 2025.
• A 5-year view of Research & Development shows it stood at $19.8 million in 2022, then surged by 37.11% to $27.1 million in 2023, then grew by 18.43% to $32.1 million in 2024, then decreased by 6.95% to $29.9 million in 2025, then slipped by 11.46% to $26.5 million in 2026.
• Business Quant data shows CMPS's Research & Development at $26.5 million in Q1 2026, $29.9 million in Q4 2025, and $27.3 million in Q3 2025.